uniQure Announces Strategic Reorganization to Reduce Operating Expenses and Support Advancement of Multiple Clinical-Stage Programs
05 oct. 2023 07h05 HE
|
uniQure Inc.
~ Reduction of 28% of workforce not related to HEMGENIX® manufacturing obligations; Total cost savings of $180 million to extend cash runway into second quarter of 2027 ~ ~ Discontinuing investments...
Superlatus, Inc. Announces New Appointments to the Management Team
27 juin 2023 08h00 HE
|
Superlatus, Inc.
NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”) (“the Company), a U.S.-based holding company of food products and distribution capabilities, which on June 23, 2023...
Porsche Cars Canada appoints new Chief Financial Officer
02 févr. 2023 09h01 HE
|
Porsche Cars Canada, Ltd.
Toronto, ON, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Porsche Cars Canada, Ltd. (PCL) is pleased to announce Annette Edel as its Chief Financial Officer, effective March 1, 2023. Edel will take the reins...
NMD Pharma appoints Dr. Jorge A. Quiroz as EVP, Chief Medical Officer
10 mai 2022 07h00 HE
|
NMD Pharma
PRESS RELEASE NMD Pharma appoints Dr. Jorge A. Quiroz as EVP, Chief Medical Officer Dr. Quiroz brings extensive US and European clinical and regulatory expertiseRole will be based in Boston,...
Blender Bites Marks Milestone Achievements While Transitioning to Major Production Stage
07 mai 2022 19h10 HE
|
Blender Bites Limited
VANCOUVER, British Columbia, May 07, 2022 (GLOBE NEWSWIRE) -- Blender Bites Ltd. (the “Company”, “Blender Bites” or “Blender”), (CSE: BITE, FWB: JL40, WKN: A3DWAM), an award-winning Canadian company...
Immunicum AB: Immunicum utser Leopold Bertea till Chief Technology Officer
05 mai 2022 02h00 HE
|
Immunicum AB
Immunicum AB (“Immunicum” publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på behandlingar mot tumörrecidiv och svårbehandlade etablerade tumörer, tillkännagav utnämningen av Leopold Bertea, PhD,...
Immunicum AB: Immunicum Appoints Leopold Bertea as Chief Technology Officer
05 mai 2022 02h00 HE
|
Immunicum AB
Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, announced the appointment of Leopold...
Blink Charging to Participate at the Capital One Securities 16th Annual Energy Conference
30 nov. 2021 09h15 HE
|
Blink Charging Co.
Miami Beach, FL, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Blink Charging Co. (Nasdaq: BLNK, BLNKW) (“Blink” or the “Company”), a leading owner, operator, and provider of electric vehicle (EV) charging...
Immunicum utser Lotta Ferm till CFO
26 oct. 2021 02h00 HE
|
Immunicum AB
Pressmeddelande 26 oktober 2021 Immunicum utser Lotta Ferm till CFO Immunicum AB (publ; IMMU.ST) tillkännagav idag att Lotta Ferm utsetts till Chief Financial Officer (CFO) från och med den 1...
Immunicum Appoints Lotta Ferm as Chief Financial Officer
26 oct. 2021 02h00 HE
|
Immunicum AB
Press Release 26 October 2021 Immunicum Appoints Lotta Ferm as Chief Financial Officer Immunicum AB (publ; IMMU.ST) today announced the appointment of Lotta Ferm as Chief Financial Officer...